A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was: What is the role of mechanical valve prostheses in pulmonary valve replacement late after tetralogy of Fallot (TOF) repair? Altogether more than 30 papers were found using the reported search, of which 9 represented the best evidence to answer the clinical question. In addition to this, two papers were found by searching the reference lists of the relevant papers. The authors, journal, date and country of publication, patient group studied, study type, relevant outcomes and results of these papers are tabulated. We conclude from the best evidence available that mechanical prosthetic valves do play a role in patients who require pulmonary valve replacement late after repair of TOF. With adequate anticoagulation, they represent a safe alternative to biological valves. Although the literature is very limited, in terms of patient numbers, many of the papers demonstrate an acceptable early mortality rate. There is significant variability in the regimes of anticoagulation in these patients, and the overall reported rate of valvar thrombosis, thromboembolic events and major haemorrhagic complications has also been variable. The overall rate of valvar thrombosis and other thromboembolic events is promising. Thrombotic events were often attributed to poor adherence to the anticoagulation regime. Conversely, 3 papers recorded no thromboembolic events during the followup period. Three papers recorded major haemorrhagic events during their follow-up period and concluded that these were a rare outcome. When appropriate anticoagulation is adhered to, mechanical pulmonary prostheses appear to be relatively safe in patients late after repair of TOF. We have also found that the rationale for insertion of mechanical valves in the pulmonary position late after TOF repair varies across centres is still controversial. Furthermore, their use in patients with concomitant pulmonary arterial stenoses may be less advisable as this will prevent future percutaneous interventions of the pulmonary arterial tree. More research is required to accurately compare the haemodynamic properties of mechanical valves in the pulmonary position compared with other valves. Additionally, a more consistent follow-up of these patients in terms of echocardiographic, valve-related and warfarin-related complications is needed. With this information, clearer conclusions may be drawn when considering their role.
INTRODUCTION
A best evidence topic was constructed according to a structured protocol. This is fully described in the ICVTS [1] . 
THREE-PART QUESTION

CLINICAL SCENARIO
A 44-year old female patient who was born with tetralogy of Fallot with major aorto-pulmonary collaterals had undergone previously four sternotomies, including a primary tetralogy repair, then a repair of residual right ventricular outflow tract obstruction and subsequently a tissue pulmonary valve replacement and pulmonary artery reconstruction. Later on she developed pulmonary valve endocarditis and required a homograft right ventricular to pulmonary artery conduit. She now has severe mixed prosthetic valve disease, right ventricular dysfunction and symptoms of breathlessness. An attempt at percutaneous valve implantation was not possible as the landing zone for the Medtronic Melody ® valve was too short. She requires a fifth sternotomy, but would rather not have any further operations following this, as the risks are becoming greater.
SEARCH OUTCOME Thirty papers were found using the reported search. From these, nine papers were identified that provided the best evidence to answer the question. In addition to this, two papers were found by searching the reference lists of the relevant papers. These are presented in Table 1 .
RESULTS
Hörer et al. [2] retrospectively compared the haemodynamic properties of 19 patients who had a pulmonary valve replacement (PVR) with a mechanical valve with those of 19 who had a biological valve. The patients were matched for age, sex and followup time. With statistical significance, they concluded that mechanical valves were initially better but declined faster. There was a high ratio of thrombosed mechanical valves. The authors concluded that mechanical valves may have a role in patients who are already on lifelong anticoagulation.
Shin et al. [3] conducted a study looking at the medical records of 37 patients who had a PVR with a mechanical valve. The durability of the mechanical valves was excellent and the rates of thromboembolic events and bleeding due to anticoagulation were low.
A cohort study performed by Stulak et al. [4] retrospectively analysed 54 patients who had PVR with mechanical valves over a period of 40 years. It showed that mechanical valves provided a high level of durability with very low risks of anticoagulation in the long term.
Dos et al. [5] performed a study with 22 consecutive patients undergoing mechanical PVRs. They showed excellent durability, again with very low levels of anticoagulant complications. They suggest that they may be a viable alternative to biological valves.
Tokunaga et al. [6] reviewed 18 patients who underwent an isolated PVR with a biological prosthesis and 6 who had a mechanical valve over a 27-year period. They concluded that there was a higher rate of valve thrombosis in the mechanical valve cohort. There was no statistically significant difference between the eventfree survival rates between the two groups.
Waterbolk et al. [7] performed a retrospective review on 28 PVRs with mechanical valves. This series refutes the bad reputation that mechanical valves in the pulmonary position have. They have observed a much lower than expected rate of reoperation and no thromboembolic events were noted.
Ovcina et al. [8] conducted a prospective study involving 24 patients who had mechanical pulmonary valves implanted. MRI was used to regularly follow these patients both during the preoperative and postoperative periods. This study demonstrated promising results. There was no evidence of valval dysfunction in the follow-up period and the rate of thromboembolic events was very low.
In a retrospective cohort study, Dreosola et al. [9] analysed the outcomes of 4 TOF patients who had a PVR late after TOF repair. The mean follow-up time was 11 years. There was no mortality and no evidence of valvar dysfunction or rhythm disturbance during the lengthy follow-up interval. All patients remained symptomatically well.
Reiss et al. [10] conducted a retrospective cohort study with 68 congenital heart disease patients with mechanical valves in situ.
Thirty-three patients had TOF. The aim of this study was to evaluate the efficacy of anticoagulation in this population. Valve thrombosis occurred in 3 TOF patients (9.1%). Mechanical valves implanted in the right side of the heart had a higher rate of valve thrombosis than valves in the left side over a mean follow-up of 72 months (range 6-132 months).
Haas et al. [11] retrospectively analysed the short-term clinical course of 14 patients who had mechanical valves implanted in the pulmonary position. Of these patients, 7 had a PVR late after TOF repair. During a mean follow-up time of mean 35 ± 22 months, there was no mortality, valve thrombosis or haemolytic anaemia.
Goor et al. [12] conducted a retrospective study of 7 patients who underwent isolated mechanical valve PVR. This small case series demonstrated that mechanical valves were a safe option from a thromboembolic risk point of view. Reintervention rates were, however, high during the follow-up period.
CLINICAL BOTTOM LINE
We conclude from the best evidence available that mechanical prosthetic valves do play a role in patients who require PVR late after repair of TOF. With adequate anticoagulation, they represent a safe alternative to biological valves. Although the literature is very limited, in terms of patient numbers, many of the papers demonstrate an acceptable early mortality rate [3, 5-9, 11, 12] . There is significant variability in the regimes of anticoagulation in these patients, and the overall reported rate of valvar thrombosis, thromboembolic events and major haemorrhagic complications has also been variable. The overall rate of valvar thrombosis and other thromboembolic events is promising [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] . One paper concluded that there was a higher rate of thrombosed valves [6] . Thrombotic events were often attributed to poor adherence to the anticoagulation regime. Conversely, three papers recorded no thromboembolic events during the follow-up period [7, 11, 12] . In patients with residual pulmonary arterial stenoses, who may require further intervention on this, it may be less prudent to use mechanical valves as it precludes any percutaneous approach in dealing with this. Longer term outcomes in any tetralogy patient is also dependent on many other factors not taken into account in this paper and include age at primary repair, type of initial repair, ventricular dysfunction, timing of PVR and many other factors. Outcome analyses will always have to be done with these in mind. Three papers recorded major haemorrhagic events during their follow-up period and concluded that these were a rare outcome [4, 5, 8] . When appropriate anticoagulation is adhered to, mechanical pulmonary prostheses appear to be relatively safe in patients late after repair of TOF.
We have also found that the rationale for insertion of mechanical valves in the pulmonary position late after TOF repair varies across centres is still controversial. Furthermore, their use in patients with concomitant pulmonary arterial stenoses may be less advisable as this will prevent future percutaneous interventions of the pulmonary arterial tree. More research is required to accurately compare the haemodynamic properties of mechanical valves in the pulmonary position compared with other valves. Additionally, a more consistent follow-up of these patients in terms of echocardiographic, valve-related and warfarin-related complications is needed. With this information, clearer conclusions may be drawn when considering their role. 
